Skip to main content
Erschienen in: International Ophthalmology 3/2023

12.09.2022 | Original Paper

A relatively low glucose promotes the proliferation of vascular endothelial cells by suppressing VEGFR2 O-GlcNAcylation and its proteasome degradation

verfasst von: Zifeng Deng

Erschienen in: International Ophthalmology | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Vascular endothelial growth factor receptors (VEGFRs) have been demonstrated to play a critical role in ischemic retinal diseases, as VEGFRs mediate hypoxia-induced neovascularization. Not only hypoxia, ischemia also induces the deficiency of glucose, yet its effects on VEGFR signal and neovascularization have seldom been studied. Bioinformatics analysis predicted that VEGFRs may be regulated by O-GlcNAcylation, while glucose deficiency influences the O-GlcNAcylation.

Methods

In this study, we treated human retinal microvascular endothelial cells with low glucose (LG) alone or in combination with low oxygen (oxygen and glucose deprivation, OGD). Cell viability and apoptosis rate were used to evaluate cell growth characters.

Results

LG (2.8 mmol/L) treatment induced mRNA and protein levels of VEGFR1, 2, 3 even in the presence of the protein synthesis inhibitor, cycloheximide (CHX), suggesting that the increase in VEGFR proteins is partially associated with post-translational modifications. Immunoprecipitation analysis showed that O-GlcNAc level was decreased by LG in both VEGFR1, 2, but a de-O-GlcNAc glycosylase inhibitor restored the O-GlcNAc levels. This inhibitor also abolished the LG-induced increase in VEGFR2 protein, whereas this effect was not disappeared in the presence of the proteasome inhibitor, MG132. Similar results were also observed under OGD condition. VEGFR2 knockdown more significantly retarded the growth of hRMECs and HUVECs than VEGFR1, 3 knockdown under LG and OGD conditions.

Conclusions

A relatively low glucose suppressed O-GlcNAcylation in VEGFR2, whereby inhibiting its proteasome degradation; up-regulated VEGFR2 promoted the proliferation of vascular endothelial cells under ischemic condition.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Le YZ (2017) VEGF production and signaling in Muller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases. Vis Res 139:108–114CrossRefPubMed Le YZ (2017) VEGF production and signaling in Muller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases. Vis Res 139:108–114CrossRefPubMed
2.
Zurück zum Zitat Chang JH, Garg NK, Lunde E, Han KY, Jain S, Azar DT (2012) Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol 57(5):415–429CrossRefPubMedPubMedCentral Chang JH, Garg NK, Lunde E, Han KY, Jain S, Azar DT (2012) Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol 57(5):415–429CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Nicholson BP, Schachat AP (2010) A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 248(7):915–930CrossRefPubMed Nicholson BP, Schachat AP (2010) A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 248(7):915–930CrossRefPubMed
4.
5.
Zurück zum Zitat Przybylski M (2009) A review of the current research on the role of bFGF and VEGF in angiogenesis. J Wound Care 18(12):516–519CrossRefPubMed Przybylski M (2009) A review of the current research on the role of bFGF and VEGF in angiogenesis. J Wound Care 18(12):516–519CrossRefPubMed
6.
Zurück zum Zitat Kennedy A, Frank RN (2011) The influence of glucose concentration and hypoxia on VEGF secretion by cultured retinal cells. Curr Eye Res 36(2):168–177CrossRefPubMed Kennedy A, Frank RN (2011) The influence of glucose concentration and hypoxia on VEGF secretion by cultured retinal cells. Curr Eye Res 36(2):168–177CrossRefPubMed
7.
Zurück zum Zitat Peng FW, Liu DK, Zhang QW, Xu YG, Shi L (2017) VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012–2016). Expert Opin Ther Pat 27(9):987–1004CrossRefPubMed Peng FW, Liu DK, Zhang QW, Xu YG, Shi L (2017) VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012–2016). Expert Opin Ther Pat 27(9):987–1004CrossRefPubMed
8.
Zurück zum Zitat Kurihara T, Westenskow PD, Friedlander M (2014) Hypoxia-inducible factor (HIF)/vascular endothelial growth factor (VEGF) signaling in the retina. Adv Exp Med Biol 801:275–281CrossRefPubMed Kurihara T, Westenskow PD, Friedlander M (2014) Hypoxia-inducible factor (HIF)/vascular endothelial growth factor (VEGF) signaling in the retina. Adv Exp Med Biol 801:275–281CrossRefPubMed
10.
Zurück zum Zitat Cong R, Sun L, Yang J et al (2021) Protein O-GlcNAcylation alleviates small intestinal injury induced by ischemia-reperfusion and oxygen-glucose deprivation. Biomed Pharmacother 138:111477CrossRefPubMed Cong R, Sun L, Yang J et al (2021) Protein O-GlcNAcylation alleviates small intestinal injury induced by ischemia-reperfusion and oxygen-glucose deprivation. Biomed Pharmacother 138:111477CrossRefPubMed
11.
Zurück zum Zitat Stephen HM, Adams TM, Wells L (2021) Regulating the regulators: mechanisms of substrate selection of the O-GlcNAc cycling enzymes OGT and OGA. Glycobiology 31(7):724–733CrossRefPubMedPubMedCentral Stephen HM, Adams TM, Wells L (2021) Regulating the regulators: mechanisms of substrate selection of the O-GlcNAc cycling enzymes OGT and OGA. Glycobiology 31(7):724–733CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Prakoso D, Lim SY, Erickson JR et al (2021) Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart. Cardiovasc Res 118(1):212–225CrossRef Prakoso D, Lim SY, Erickson JR et al (2021) Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart. Cardiovasc Res 118(1):212–225CrossRef
13.
Zurück zum Zitat Lin CH, Liao CC, Chen MY, Chou TY (2021) Feedback regulation of O-GlcNAc transferase through translation control to maintain intracellular O-GlcNAc homeostasis. Int J Mol Sci 22(7):3463CrossRefPubMedPubMedCentral Lin CH, Liao CC, Chen MY, Chou TY (2021) Feedback regulation of O-GlcNAc transferase through translation control to maintain intracellular O-GlcNAc homeostasis. Int J Mol Sci 22(7):3463CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Chatham JC, Zhang J, Wende AR (2021) Role of O-linked N-acetylglucosamine protein modification in cellular (patho) physiology. Physiol Rev 101(2):427–493CrossRefPubMed Chatham JC, Zhang J, Wende AR (2021) Role of O-linked N-acetylglucosamine protein modification in cellular (patho) physiology. Physiol Rev 101(2):427–493CrossRefPubMed
15.
Zurück zum Zitat Chandler KB, Leon DR, Kuang J, Meyer RD, Rahimi N, Costello CE (2019) N-Glycosylation regulates ligand-dependent activation and signaling of vascular endothelial growth factor receptor 2 (VEGFR2). J Biol Chem 294(35):13117–13130CrossRefPubMedPubMedCentral Chandler KB, Leon DR, Kuang J, Meyer RD, Rahimi N, Costello CE (2019) N-Glycosylation regulates ligand-dependent activation and signaling of vascular endothelial growth factor receptor 2 (VEGFR2). J Biol Chem 294(35):13117–13130CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kang HT, Ju JW, Cho JW, Hwang ES (2003) Down-regulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic, 2-deoxyglucose. J Biol Chem 278(51):51223–51231CrossRefPubMed Kang HT, Ju JW, Cho JW, Hwang ES (2003) Down-regulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic, 2-deoxyglucose. J Biol Chem 278(51):51223–51231CrossRefPubMed
17.
Zurück zum Zitat Rahimi N (2009) A role for protein ubiquitination in VEGFR-2 signalling and angiogenesis. Biochem Soc Trans 37(Pt 6):1189–1192CrossRefPubMed Rahimi N (2009) A role for protein ubiquitination in VEGFR-2 signalling and angiogenesis. Biochem Soc Trans 37(Pt 6):1189–1192CrossRefPubMed
18.
Zurück zum Zitat Wang H, Zhou J, Sun C, Dong X (2021) Effects of novel anti-VEGF agents with intravitreal conbercept in diabetic retinopathy: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2021:9357108PubMedPubMedCentral Wang H, Zhou J, Sun C, Dong X (2021) Effects of novel anti-VEGF agents with intravitreal conbercept in diabetic retinopathy: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2021:9357108PubMedPubMedCentral
19.
Zurück zum Zitat Elnahry AG, Abdel-Kader AA, Habib AE, Elnahry GA, Raafat KA, Elrakhawy K (2020) Review on recent trials evaluating the effect of intravitreal injections of anti-VEGF agents on the macular perfusion of diabetic patients with diabetic macular edema. Rev Recent Clin Trials 15(3):188–198PubMedPubMedCentral Elnahry AG, Abdel-Kader AA, Habib AE, Elnahry GA, Raafat KA, Elrakhawy K (2020) Review on recent trials evaluating the effect of intravitreal injections of anti-VEGF agents on the macular perfusion of diabetic patients with diabetic macular edema. Rev Recent Clin Trials 15(3):188–198PubMedPubMedCentral
20.
Zurück zum Zitat Falcon BL, Chintharlapalli S, Uhlik MT, Pytowski B (2016) Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents. Pharmacol Ther 164:204–225CrossRefPubMed Falcon BL, Chintharlapalli S, Uhlik MT, Pytowski B (2016) Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents. Pharmacol Ther 164:204–225CrossRefPubMed
21.
Zurück zum Zitat Chandler KB, Leon DR, Meyer RD, Rahimi N, Costello CE (2017) Site-specific N-glycosylation of endothelial cell receptor tyrosine kinase VEGFR-2. J Proteome Res 16(2):677–688CrossRefPubMed Chandler KB, Leon DR, Meyer RD, Rahimi N, Costello CE (2017) Site-specific N-glycosylation of endothelial cell receptor tyrosine kinase VEGFR-2. J Proteome Res 16(2):677–688CrossRefPubMed
22.
Zurück zum Zitat Sasaki H, Ray PS, Zhu L, Galang N, Maulik N (2000) Oxidative stress due to hypoxia/reoxygenation induces angiogenic factor VEGF in adult rat myocardium: possible role of NFkappaB. Toxicology 155(1–3):27–35CrossRefPubMed Sasaki H, Ray PS, Zhu L, Galang N, Maulik N (2000) Oxidative stress due to hypoxia/reoxygenation induces angiogenic factor VEGF in adult rat myocardium: possible role of NFkappaB. Toxicology 155(1–3):27–35CrossRefPubMed
23.
Zurück zum Zitat Eichler W, Kuhrt H, Hoffmann S, Wiedemann P, Reichenbach A (2000) VEGF release by retinal glia depends on both oxygen and glucose supply. NeuroReport 11(16):3533–3537CrossRefPubMed Eichler W, Kuhrt H, Hoffmann S, Wiedemann P, Reichenbach A (2000) VEGF release by retinal glia depends on both oxygen and glucose supply. NeuroReport 11(16):3533–3537CrossRefPubMed
24.
Zurück zum Zitat Singh AJ, Meyer RD, Navruzbekov G et al (2007) A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis. Proc Natl Acad Sci USA 104(13):5413–5418CrossRefPubMedPubMedCentral Singh AJ, Meyer RD, Navruzbekov G et al (2007) A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis. Proc Natl Acad Sci USA 104(13):5413–5418CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Ohnuki H, Inoue H, Takemori N et al (2012) BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesis. Blood 119(11):2688–2698CrossRefPubMed Ohnuki H, Inoue H, Takemori N et al (2012) BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesis. Blood 119(11):2688–2698CrossRefPubMed
26.
Zurück zum Zitat Stevens M, Oltean S (2019) Modulation of receptor tyrosine kinase activity through alternative splicing of ligands and receptors in the VEGF-A/VEGFR axis. Cells 8(4):288CrossRefPubMedPubMedCentral Stevens M, Oltean S (2019) Modulation of receptor tyrosine kinase activity through alternative splicing of ligands and receptors in the VEGF-A/VEGFR axis. Cells 8(4):288CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Thomas JL, Baker K, Han J et al (2013) Interactions between VEGFR and Notch signaling pathways in endothelial and neural cells. Cell Mol Life Sci 70(10):1779–1792CrossRefPubMedPubMedCentral Thomas JL, Baker K, Han J et al (2013) Interactions between VEGFR and Notch signaling pathways in endothelial and neural cells. Cell Mol Life Sci 70(10):1779–1792CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Yu Z, Zhang T, Gong C et al (2016) Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1alpha-VEGF/VEGFR2 signaling pathway. Sci Rep 6:34306CrossRefPubMedPubMedCentral Yu Z, Zhang T, Gong C et al (2016) Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1alpha-VEGF/VEGFR2 signaling pathway. Sci Rep 6:34306CrossRefPubMedPubMedCentral
Metadaten
Titel
A relatively low glucose promotes the proliferation of vascular endothelial cells by suppressing VEGFR2 O-GlcNAcylation and its proteasome degradation
verfasst von
Zifeng Deng
Publikationsdatum
12.09.2022
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 3/2023
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-022-02492-2

Weitere Artikel der Ausgabe 3/2023

International Ophthalmology 3/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.